- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07315646
Pijn geassocieerd met traditionele versus echogeleide IUS (intra-uteriene systeem) insertie (PAINLESS)
De PAINLESS-studie: Pijn geassocieerd met traditionele versus echogeleide iuS (intra-uterien systeem) insertie
Rationale: The 2019 Belgian Health Survey shows that the combined oral contraceptive pill is the most commonly used form of contraception. However, the Pearl index of Long-acting reversible contraceptive (LARC) methods is significantly better (perfect and typical use <0.5) compared to the combined oral contraceptive pill (perfect use <1.0, typical use 2-9). An IUS is an example of a LARC method. IUS insertion might be painful. Because of this, women may be reluctant to opt for an IUS. The traditional technique for an IUS insertion uses a speculum after which a Pozzi tenaculum is placed on the cervix so that the uterus is brought into the stretching position by means of traction. The cavum is then measured by a uterine sound. These actions and the use of these instruments can contribute to the pain experience during insertion. The new technique, transabdominal sonographic (TAS) insertion, could reduce the pain experience during insertion. This new technique uses transabdominal sonography during IUS placement. The placement under constant visualization eliminates the need for Pozzi tenaculum and uterine soundings. Little high quality studies have been conducted on the advantages and disadvantages of the TAS technique as demonstrated by a non-published systematic review of the literature.
Research question/goal: Is the insertion of an IUS (Kyleena/Mirena) using the TAS technique less painful than the traditional technique?
Study design: A randomized trial (RCT) in which the subject is blinded to the insertion technique.
Study population: Women wishing an IUS (Kyleena & Mirena)
Primary and secondary outcomes:
The primary outcomes are the pain during insertion (Numeric Rating Scale (NRS) score 0-10) and dislocation: non-fundal position (> 3mm fundal distance postinsertion) in the uterine cavity (Y/N).
Secondary outcomes include the average and worst pain in the first week after insertion (NRS 0-10), expulsion of the IUS, perforation of the uterine wall, failure of insertion, the occurrence of vagal symptoms, use of pain relief the first 7 days after placement, subject satisfaction about the procedure, successful IUS placement.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Ghent, België, 9000
- Ghent University Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Women between18 years and 60 years (at the time of signing the ICF)
- Who wish to have an IUS (Kyleena/Mirena) for reasons of family planning, conservative treatment for abnormal uterine bleeding or as part of hormonal treatment for menopausal symptoms
- Dutch-speaking subjects
Exclusion Criteria:
- History of difficult IUS placement
- Known cervical stenosis
- Asherman's syndrome
- Standard contraindications to an IUS (eg breast cancer, recent deep vein thrombosis, anatomical uterine abnormalities, pregnancy, acute PID, cervicitis, vaginitis or any lower genital tract infection, cervical or endometrial malignancy, history of septic abortion or postpartum endometritis in the last 3 months,.. )
- Current pelvic inflammatory disease
- Pregnancy
- Trophoblastic disease
- Known cervical or endometrial carcinoma
- Patients who have the profession of midwife, nurse or doctor.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: The TAS (transabominal ultrasound) insertion technique
This new technique uses transabdominal sonography during IUS placement. The placement under constant visualization eliminates the need for Pozzi tenaculum and uterine soundings. |
Intra-uterine device insertion (technique based on randomization arm) |
|
Actieve vergelijker: The Traditional Technique
The traditional technique for an IUS insertion uses a speculum after which a Pozzi tenaculum is placed on the cervix so that the uterus is brought into the stretching position by means of traction. The cavum is then measured by a uterine sound. These actions and the use of these instruments can contribute to the pain experience during insertion. |
Intra-uterine device insertion (technique based on randomization arm) |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Pain during insertion of the IUS
Tijdsspanne: From enrollment to the intervention date (IUS placement)
|
Pain during insertion, reported by the subject on a Numeric Rating Scale (NRS scale) 0-10 |
From enrollment to the intervention date (IUS placement)
|
|
Dislocation
Tijdsspanne: From enrollment to intervention date (IUS placement)
|
Dislocation: non-fundal position (> 3mm fundal distance postinsertion) in the uterine cavity (Y/N) |
From enrollment to intervention date (IUS placement)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Expulsion
Tijdsspanne: During of directly after the intervention (IUS placement)
|
Expulsion of the IUS during the procedure (Y/N) |
During of directly after the intervention (IUS placement)
|
|
Failure of insertion
Tijdsspanne: During the procedure of IUS placement
|
Failure of insertion (yes/no) |
During the procedure of IUS placement
|
|
vagal symptoms
Tijdsspanne: During IUD insertion
|
Vagal symptoms: paillor, sweating, syncope (yes/no) |
During IUD insertion
|
|
Pain experience during 7 days after placement
Tijdsspanne: During the 7 days after IUS insertion
|
Pain experience (average and worst pain) during 7 days after placement (NRS 0-10) |
During the 7 days after IUS insertion
|
|
Pain relief taken during the 7 days after IUS placement
Tijdsspanne: During the 7 days after IUS placement
|
Pain relief taken during the 7 days after placement (Y/N, if yes specify in text field (what, dose, timing)) |
During the 7 days after IUS placement
|
|
Satisfaction with the procedure
Tijdsspanne: Seven days after IUS placement
|
Subject satisfaction with the technique (5 point Likert scale) |
Seven days after IUS placement
|
|
Successful IUS placement
Tijdsspanne: Directly after IUS insertion procedure
|
Successful IUS placement (Y/N) |
Directly after IUS insertion procedure
|
|
Perforation
Tijdsspanne: During IUS placement
|
Perforation: IUS perforates the uterine wall (Y/N). Characterized by sharp pain and blood loss during insertion, ultrasound extrauterine position in total perforation or positioned in the myometrium in partial perforation. |
During IUS placement
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Steven Weyers, MD, PhD, University Hospital, Ghent
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- ONZ-2025-0220
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .